111 related articles for article (PubMed ID: 26407335)
21. The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model.
Blank M; Anafi L; Zandman-Goddard G; Krause I; Goldman S; Shalev E; Cervera R; Font J; Fridkin M; Thiesen HJ; Shoenfeld Y
Int Immunol; 2007 Jul; 19(7):857-65. PubMed ID: 17576752
[TBL] [Abstract][Full Text] [Related]
22. Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders.
Omwandho CO; Gruessner SE; Roberts TK; Tinneberg HR
Clin Chem Lab Med; 2004 Apr; 42(4):359-70. PubMed ID: 15147144
[TBL] [Abstract][Full Text] [Related]
23. Anti α-enolase antibody is a novel autoimmune biomarker for unexplained recurrent miscarriages.
Ye Y; Kuhn C; Kösters M; Arnold GJ; Ishikawa-Ankerhold H; Schulz C; Rogenhofer N; Thaler CJ; Mahner S; Fröhlich T; Jeschke U; von Schönfeldt V
EBioMedicine; 2019 Mar; 41():610-622. PubMed ID: 30827932
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D deficiency may be a risk factor for recurrent pregnancy losses by increasing cellular immunity and autoimmunity.
Ota K; Dambaeva S; Han AR; Beaman K; Gilman-Sachs A; Kwak-Kim J
Hum Reprod; 2014 Feb; 29(2):208-19. PubMed ID: 24277747
[TBL] [Abstract][Full Text] [Related]
25. Treatment with intravenous immunoglobulin in patients with recurrent pregnancy loss: An update.
Christiansen OB; Kolte AM; Krog MC; Nielsen HS; Egerup P
J Reprod Immunol; 2019 Jun; 133():37-42. PubMed ID: 31238263
[TBL] [Abstract][Full Text] [Related]
26. Heparanase expression correlates with metastatic capability in human choriocarcinoma.
Jingting C; Yangde Z; Yi Z; Huining L; Rong Y; Yu Z
Gynecol Oncol; 2007 Oct; 107(1):22-9. PubMed ID: 17688924
[TBL] [Abstract][Full Text] [Related]
27. Alterations in antibody subclass immune reactivity to trophoblast-derived fetal fibronectin and α2-macroglobulin in women with recurrent pregnancy loss.
Saunders RD; Nakajima ST; Rai SN; Pan J; Gercel-Taylor C; Taylor DD
Am J Reprod Immunol; 2012 Nov; 68(5):438-49. PubMed ID: 22935024
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness and potential mechanisms of intralipid in treating unexplained recurrent spontaneous abortion.
Meng L; Lin J; Chen L; Wang Z; Liu M; Liu Y; Chen X; Zhu L; Chen H; Zhang J
Arch Gynecol Obstet; 2016 Jul; 294(1):29-39. PubMed ID: 26671484
[TBL] [Abstract][Full Text] [Related]
29. The influence of intravenous immunoglobulin treatment on maternal immunity in women with unexplained recurrent miscarriage.
Maruyama T; Makino T; Iwasaki K; Sugi T; Saito S; Umeuchi M; Ozawa N; Matsubayashi H; Nozawa S
Am J Reprod Immunol; 1994 Jan; 31(1):7-18. PubMed ID: 8166949
[TBL] [Abstract][Full Text] [Related]
30. Biological activity of the suppressor cells inducer factor secreted by the Jeg-3 choriocarcinoma cell line.
Markert UR; Chaouat G
Am J Reprod Immunol; 2001 Nov; 46(5):332-41. PubMed ID: 11712762
[TBL] [Abstract][Full Text] [Related]
31. [Studies on HLA-class I and class II antigen expression in cultured choriocarcinoma cell lines].
Yamashita K; Nakamura T; Shimizu T; Ikeda H; Katagiri M
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):17-22. PubMed ID: 3512743
[TBL] [Abstract][Full Text] [Related]
32. Resistance of uterine radial artery blood flow was correlated with peripheral blood NK cell fraction and improved with low molecular weight heparin therapy in women with unexplained recurrent pregnancy loss.
Koo HS; Kwak-Kim J; Yi HJ; Ahn HK; Park CW; Cha SH; Kang IS; Yang KM
Am J Reprod Immunol; 2015 Feb; 73(2):175-84. PubMed ID: 25339113
[TBL] [Abstract][Full Text] [Related]
33. Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin.
Stricker RB; Winger EE
Am J Reprod Immunol; 2005 Dec; 54(6):390-6. PubMed ID: 16305665
[TBL] [Abstract][Full Text] [Related]
34. Hyperglycaemia in vitro alters the proliferation and mitochondrial activity of the choriocarcinoma cell lines BeWo, JAR and JEG-3 as models for human first-trimester trophoblast.
Weiss U; Cervar M; Puerstner P; Schmut O; Haas J; Mauschitz R; Arikan G; Desoye G
Diabetologia; 2001 Feb; 44(2):209-19. PubMed ID: 11270678
[TBL] [Abstract][Full Text] [Related]
35. Primary chronic abortion, preeclampsia, idiopathic intrauterine growth retardation, hydatidiform mole, and choriocarcinoma: a unifying concept.
Labarrere CA; Althabe OH
Am J Reprod Immunol Microbiol; 1986 Apr; 10(4):156-7. PubMed ID: 3706608
[TBL] [Abstract][Full Text] [Related]
36. Anti-idiotypes against antiphospholipid antibodies are present in normal polyspecific immunoglobulins for therapeutic use.
Caccavo D; Vaccaro F; Ferri GM; Amoroso A; Bonomo L
J Autoimmun; 1994 Aug; 7(4):537-48. PubMed ID: 7980854
[TBL] [Abstract][Full Text] [Related]
37. Crucial cross-talk of interleukin-1β and progesterone in human choriocarcinoma.
Zachariades E; Mparmpakas D; Thomas P; Rand-Weaver M; Karteris E
Int J Oncol; 2012 May; 40(5):1358-64. PubMed ID: 22294087
[TBL] [Abstract][Full Text] [Related]
38. A possible coagulation-independent mechanism for pregnancy loss involving β(2) glycoprotein 1-dependent antiphospholipid antibodies and CD1d.
Iwasawa Y; Kawana K; Fujii T; Schust DJ; Nagamatsu T; Kawana Y; Sayama S; Miura S; Matsumoto J; Adachi K; Hyodo H; Yamashita T; Kozuma S; Taketani Y
Am J Reprod Immunol; 2012 Jan; 67(1):54-65. PubMed ID: 21682789
[TBL] [Abstract][Full Text] [Related]
39. The effect of interleukin-17 on the proliferation and invasion of JEG-3 human choriocarcinoma cells.
Pongcharoen S; Niumsup P; Sanguansermsri D; Supalap K; Butkhamchot P
Am J Reprod Immunol; 2006 Apr; 55(4):291-300. PubMed ID: 16533341
[TBL] [Abstract][Full Text] [Related]
40. Celiac disease serum markers and recurrent pregnancy loss.
Sharshiner R; Romero ST; Bardsley TR; Branch DW; Silver RM
J Reprod Immunol; 2013 Dec; 100(2):104-8. PubMed ID: 24176553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
